logo
Plus   Neg
Share
Email

Dr. Reddy's To Sell Migraine Drugs Tosymra, Zembrace To Upsher-Smith Labs

Dr. Reddy's Laboratories Ltd. (RDY,DRREDDY) announced Friday that it has entered into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC.

The company would sell its US and select territory rights for ZEMBRACE SYMTOUCH (sumatriptan injection) 3 mg and TOSYMRA (sumatriptan nasal spray) 10 mg, formerly referred to as "DFN-02". These are commercialized through the company's unit Promius Pharma, LLC.

Under the deal, Dr. Reddy's will receive $70 million as upfront consideration, $40.5 million in near term milestones, as well as additional financial considerations including existing contractual obligation and inventory.

Subsequently, Dr. Reddy's will receive sales based royalties on a quarterly basis.

The closing of the sale is subject to various customary closing conditions including antitrust review under Hart-Scott-Rodino Act.

Anil Namboodiripad, Senior Vice President, Proprietary Products and Head, Promius Pharma, said, "Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete segments of patients suffering from episodic migraine who need options other than their current therapies."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT